Literature DB >> 12130543

The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1.

Dagmar Wilhelm1, Christoph Englert.   

Abstract

In mammals, several genes including the Wilms tumor suppressor gene Wt1, the Lim homeobox gene Lhx9, and the gene encoding steroidogenic factor 1 (Sf1) have been implicated in the development of the indifferent gonad prior to sexual differentiation. Interactions among these genes have not yet been elucidated. Using biochemical and genetic experiments, we demonstrate here that WT1 and LHX9 function as direct activators of the Sf1 gene. Interestingly, only the -KTS form of WT1 is able to bind to and transactivate the Sf1 promoter. This observation is consistent with differential roles for the -KTS and +KTS variants of WT1 which have been postulated on the basis of human disorders such as the Frasier syndrome. Our data suggest a pathway in which the products of the Wt1 and Lhx9 genes activate expression of Sf1 and thus mediate early gonadogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12130543      PMCID: PMC186395          DOI: 10.1101/gad.220102

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  48 in total

1.  A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans.

Authors:  J C Achermann; M Ito; M Ito; P C Hindmarsh; J L Jameson
Journal:  Nat Genet       Date:  1999-06       Impact factor: 38.330

2.  Tumor-associated WT1 missense mutants indicate that transcriptional activation by WT1 is critical for growth control.

Authors:  M A English; J D Licht
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

3.  Induction of p21 by the Wilms' tumor suppressor gene WT1.

Authors:  C Englert; S Maheswaran; A J Garvin; J Kreidberg; D A Haber
Journal:  Cancer Res       Date:  1997-04-15       Impact factor: 12.701

4.  The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin.

Authors:  S B Lee; K Huang; R Palmer; V B Truong; D Herzlinger; K A Kolquist; J Wong; C Paulding; S K Yoon; W Gerald; J D Oliner; D A Haber
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

5.  Dax-1 as one of the target genes of Ad4BP/SF-1.

Authors:  K Kawabe; T Shikayama; H Tsuboi; S Oka; K Oba; T Yanase; H Nawata; K Morohashi
Journal:  Mol Endocrinol       Date:  1999-08

6.  WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene.

Authors:  M W Mayo; C Y Wang; S S Drouin; L V Madrid; A F Marshall; J C Reed; B E Weissman; A S Baldwin
Journal:  EMBO J       Date:  1999-07-15       Impact factor: 11.598

Review 7.  Genes essential for early events in gonadal development.

Authors:  K L Parker; B P Schimmer; A Schedl
Journal:  Cell Mol Life Sci       Date:  1999-06       Impact factor: 9.261

8.  The Wilms tumor suppressor gene wt1 is required for development of the spleen.

Authors:  U Herzer; A Crocoll; D Barton; N Howells; C Englert
Journal:  Curr Biol       Date:  1999 Jul 29-Aug 12       Impact factor: 10.834

9.  Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.

Authors:  J Pelletier; W Bruening; C E Kashtan; S M Mauer; J C Manivel; J E Striegel; D C Houghton; C Junien; R Habib; L Fouser
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

10.  The transcriptional effect of WT1 is modulated by choice of expression vector.

Authors:  J C Reddy; S Hosono; J D Licht
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

View more
  72 in total

Review 1.  Candidate genes and potential targets for therapeutics in Wilms' tumour.

Authors:  Christopher Blackmore; Max J Coppes; Aru Narendran
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

2.  Evolutionarily conserved regulation of hypocretin neuron specification by Lhx9.

Authors:  Justin Liu; Florian T Merkle; Avni V Gandhi; James A Gagnon; Ian G Woods; Cindy N Chiu; Tomomi Shimogori; Alexander F Schier; David A Prober
Journal:  Development       Date:  2015-02-27       Impact factor: 6.868

3.  A FTZ-F1-containing yeast artificial chromosome recapitulates expression of steroidogenic factor 1 in vivo.

Authors:  Tatiana Karpova; Jeremy Presley; Rengasamy R Manimaran; Serge P Scherrer; Lovella Tejada; Kenneth R Peterson; Leslie L Heckert
Journal:  Mol Endocrinol       Date:  2005-06-16

4.  Interrenal organogenesis in the zebrafish model.

Authors:  Yi-Wen Liu
Journal:  Organogenesis       Date:  2007-01       Impact factor: 2.500

5.  Adrenal Development in Mice Requires GATA4 and GATA6 Transcription Factors.

Authors:  Sergei G Tevosian; Elizabeth Jiménez; Heather M Hatch; Tianyu Jiang; Deborah A Morse; Shawna C Fox; Maria B Padua
Journal:  Endocrinology       Date:  2015-05-01       Impact factor: 4.736

6.  Developmental links between the fetal and adult zones of the adrenal cortex revealed by lineage tracing.

Authors:  Mohamad Zubair; Keith L Parker; Ken-ichirou Morohashi
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

Review 7.  The mammalian ovary from genesis to revelation.

Authors:  Mark A Edson; Ankur K Nagaraja; Martin M Matzuk
Journal:  Endocr Rev       Date:  2009-09-23       Impact factor: 19.871

8.  The Wilms tumor gene, Wt1, is required for Sox9 expression and maintenance of tubular architecture in the developing testis.

Authors:  Fei Gao; Sourindra Maiti; Nargis Alam; Zhen Zhang; Jian Min Deng; Richard R Behringer; Charlotte Lécureuil; Florian Guillou; Vicki Huff
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-28       Impact factor: 11.205

9.  Mapping lineage progression of somatic progenitor cells in the mouse fetal testis.

Authors:  Chang Liu; Karina Rodriguez; Humphrey H-C Yao
Journal:  Development       Date:  2016-09-12       Impact factor: 6.868

Review 10.  Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development.

Authors:  L Lin; J C Achermann
Journal:  Sex Dev       Date:  2008-11-05       Impact factor: 1.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.